HuGE Literature Finder
Records
1
-
7
Association of CNR1 and INSIG2 polymorphisms with antipsychotics-induced weight gain: a prospective nested case-control study. Scientific reports 2021 Jul 11 (1): 15304. Jimeno Natalia, Velasco-Gonzalez Veronica, Fierro Inmaculada, Duran Mercedes, Carvajal Alfon |
INSIG2 polymorphism and weight gain, dyslipidemia and serum adiponectin in Finnish patients with schizophrenia treated with clozapine. Pharmacogenomics 2016 Dec 17 (18): 1987-1997. Koskinen Suvi, Kampman Olli, Solismaa Anssi, Lyytikäinen Leo-Pekka, Seppälä Niko, Viikki Merja, Hämäläinen Mari, Moilanen Eeva, Mononen Nina, Lehtimäki Terho, Leinonen E |
Pharmacogenetic Associations of Antipsychotic Drug-Related Weight Gain: A Systematic Review and Meta-analysis. Schizophrenia bulletin 2016 May . Zhang Jian-Ping, Lencz Todd, Zhang Ryan X, Nitta Masahiro, Maayan Lawrence, John Majnu, Robinson Delbert G, Fleischhacker W Wolfgang, Kahn Rene S, Ophoff Roel A, Kane John M, Malhotra Anil K, Correll Christoph |
Obesity and diabetes genetic variants associated with gestational weight gain. American journal of obstetrics and gynecology 2010 Sep 203 (3): 283.e1-17. Stuebe Alison M, Lyon Helen, Herring Amy H, Ghosh Joyee, Wise Alison, North Kari E, Siega-Riz Anna Mar |
Association of HTR2C, but not LEP or INSIG2, genes with antipsychotic-induced weight gain in a German sample. Pharmacogenomics 2010 Jun 11 (6): 773-80. Opgen-Rhein Carolin, Brandl Eva Janina, Müller Daniel J, Neuhaus Andres H, Tiwari Arun K, Sander Thomas, Dettling Micha |
Association study of polymorphisms in insulin induced gene 2 (INSIG2) with antipsychotic-induced weight gain in European and African-American schizophrenia patients. Human psychopharmacology 2010 Apr 25 (3): 253-9. Tiwari Arun K, Zai Clement C, Meltzer Herbert Y, Lieberman Jeffrey A, Müller Daniel J, Kennedy James |
Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects? Molecular psychiatry 2009 Mar 14 (3): 308-17. Le Hellard S, Theisen F M, Haberhausen M, Raeder M B, Fernø J, Gebhardt S, Hinney A, Remschmidt H, Krieg J C, Mehler-Wex C, Nöthen M M, Hebebrand J, Steen V |
- Page last reviewed:Jul 25, 2022
- Page last updated:Jan 27, 2023
- Content source: